Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Clinical trial NCT01244750 · COMPLETED

Trial details

NCT number: NCT01244750
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia

Start date: 2010-12-02
Primary completion: 2020-01-08
Enrollment: 1494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.